2012
DOI: 10.14573/altex.2012.2.202
|View full text |Cite
|
Sign up to set email alerts
|

Advancing the science of developmental neurotoxicity (DNT): testing for better safety evaluation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
73
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
8
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 99 publications
(73 citation statements)
references
References 89 publications
0
73
0
Order By: Relevance
“…A better understanding of the developmental processes and how toxicants affect them is important to identify the causes and to develop strategies to avoid them (Barouki et al, 2012;Grandjean and Landrigan, 2014). This applies to a particularly high degree to the field of developmental neurotoxicity (DNT) (Bal-Price et al, 2012;Crofton et al, 2012).…”
Section: Ncc Differentiationmentioning
confidence: 99%
“…A better understanding of the developmental processes and how toxicants affect them is important to identify the causes and to develop strategies to avoid them (Barouki et al, 2012;Grandjean and Landrigan, 2014). This applies to a particularly high degree to the field of developmental neurotoxicity (DNT) (Bal-Price et al, 2012;Crofton et al, 2012).…”
Section: Ncc Differentiationmentioning
confidence: 99%
“…Uses of the zebrafish assay (Selderslaghs et al, 2011;Padilla et al, 2012;truong et al, 2014), the embryonic stem cell test (eSt) (van Dartel and Piersma, 2011;Seiler and Spielmann, 2011) and further developments on the basis of ReProtect test systems (Piersma, 2010) could immediately fill the gap until assays based on human cells become available. The field is developing very dynamically, and, especially in the area of developmental neurotoxicity, many new test systems are emerging (Zimmer et al, 2014;Smirnova et al, 2014;Bal-Price et al, 2012). the new assays will need to be assembled into an advanced test battery using concepts of ItS design (Fig.…”
Section: Fig 13: Schematic Explanation Of Quantitative In Vitro -In mentioning
confidence: 99%
“…The consortium has shown that complex functional endpoints can be transferred to in vitro test systems Kadereit et al 2012;Zimmer et al 2012). The availability of both murine and human stem cells even allows species comparisons in vitro and puts species extrapolations from available rodent data to humans on a rational basis (Bal-Price et al 2012). Thanks to induced PSC technology (Takahashi and Yamanaka 2006), the ethnic diversity of humans can be included into the analysis through a careful selection of PSC lines (Fakunle and Loring 2012).…”
mentioning
confidence: 99%